Patents by Inventor Wangjin XU

Wangjin XU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED HETEROARYL COMPOUND, AND COMPOSITION AND APPLICATION THEREOF
    Publication number: 20230339977
    Abstract: A substituted heteroaryl compound, and a composition and application thereof. The compound is a compound as represented by formula (I) or a stereoisomer, a tautomer, an oxynitride, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug of the compound as represented by formula (I). A drug composition contains the compound. The compound and the drug composition can adjust activity of a JAK kinase, particularly activity of TYK2, and are used for preventing, handling, treating and relieving diseases or disorder mediated by the activity of the JAK kinase.
    Type: Application
    Filed: August 12, 2021
    Publication date: October 26, 2023
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Ning XI, Bin WANG, Wuhong CHEN, Peng CHEN, Changlin BAI, Wangjin XU, Minxiong LI, Shuying CHEN